Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The year's new drugs.

A I Graul

    Drug News & Perspectives
    |August 26, 2003
    PubMed
    Summary
    This summary is machine-generated.

    In 1999, 44 new drugs and 2 diagnostic agents launched. The endocrine system saw the most new drug approvals, with the United States leading market introductions.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The year's new drugs and biologics 2020.

    Drugs of today (Barcelona, Spain : 1998)·2021
    Same author

    The year's new drugs and biologics 2019.

    Drugs of today (Barcelona, Spain : 1998)·2020
    Same author

    The year's new drugs and biologics 2018: Part II - News that shaped the industry in 2018.

    Drugs of today (Barcelona, Spain : 1998)·2019
    Same author

    The year's new drugs and biologics 2018: Part I.

    Drugs of today (Barcelona, Spain : 1998)·2019
    Same author

    The year's new drugs & biologics, 2017, part II - News that shaped the industry in 2017.

    Drugs of today (Barcelona, Spain : 1998)·2018
    Same author

    The year's new drugs and biologics 2017: Part I.

    Drugs of today (Barcelona, Spain : 1998)·2018

    Area of Science:

    • Pharmaceuticals and Therapeutics
    • Drug Discovery and Development
    • Market Analysis

    Background:

    • The year 1999 marked a significant period for new product introductions in the pharmaceutical industry.
    • Tracking new market entrants is crucial for understanding therapeutic advancements and market dynamics.

    Purpose of the Study:

    • To analyze the landscape of new chemical entities, biological drugs, and diagnostic agents launched in 1999.
    • To identify the most active therapeutic areas and geographical markets for these new product introductions.

    Main Methods:

    • Data compilation of all new market introductions in 1999.
    • Categorization of new products by therapeutic class and geographical market.
    • Analysis of launch numbers for different drug types and regions.

    Related Experiment Videos

    Main Results:

    • A total of 44 new chemical entities and biological drugs, along with 2 diagnostic agents, were introduced to the market in 1999.
    • Endocrine Drugs emerged as the most active therapeutic group with nine new market introductions.
    • The United States led in new product launches, accounting for 23 introductions, representing 50% of the global total for the year.

    Conclusions:

    • The pharmaceutical market in 1999 was characterized by a substantial number of new drug and diagnostic agent launches.
    • Endocrine-related therapies were a key focus for development and market entry.
    • The United States served as the primary market for new pharmaceutical products during this period.